Source: Biospectrum Asia

Genesis Capital, LLC: Genesis Capital invests in Australian firm Crux Biolabs

Genesis Capital invests in Crux Biolabs, a leading bioanalytical laboratory to the clinical trials sector

Read full article »
Genesis Capital, LLC's Competitors | Genesis Capital, LLC's News | Genesis Capital, LLC's Financials
Stay up-to-date with the latest news on Genesis Capital, LLC
Est. Annual Revenue
$5.0-25M
Est. Employees
1-25
Jonathan D Goldman's photo - CEO of Genesis Capital, LLC

CEO

Jonathan D Goldman

CEO Approval Rating

85/100

Read more
Stay up-to-date with the latest news on Genesis Capital, LLC